Related references
Note: Only part of the references are listed.HIV Sequence Variation Associated With env Antisense Adoptive T-cell Therapy in the hNSG Mouse Model
Rithun Mukherjee et al.
MOLECULAR THERAPY (2010)
RNA-Based Gene Therapy for HIV With Lentiviral Vector-Modified CD34+ Cells in Patients Undergoing Transplantation for AIDS-Related Lymphoma
David L. DiGiusto et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Drug-resistant human immunodefiency virus
M. J. Kozal
CLINICAL MICROBIOLOGY AND INFECTION (2009)
Protein Scaffold and Expression Level Determine Antiviral Activity of Membrane-Anchored Antiviral Peptides
Felix G. Hermann et al.
HUMAN GENE THERAPY (2009)
Long-Term Control of HIV by CCR5 Delta32/Delta32 Stem-Cell Transplantaion
Gero Huetter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Efficient entry inhibition of human and nonhuman primate immunodeficiency virus by cell surface-expressed gp41-derived peptides
R. C. Zahn et al.
GENE THERAPY (2008)
Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases
Elena E. Perez et al.
NATURE BIOTECHNOLOGY (2008)
The role of collagen deposition in depleting CD4+T cells and limiting reconstitution in HIV-1 and SIV infections through damage to the secondary lymphoid organ niche
Jacob D. Estes et al.
SEMINARS IN IMMUNOLOGY (2008)
Genetic therapies against HIV
John J. Rossi et al.
NATURE BIOTECHNOLOGY (2007)
Stable reduction of CCR5 by RNAi through hematopoietic stem cell transplant in non-human primates
Dong Sung An et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Transfer of autologous gene-modified T cells in HIV-infected patients with advanced immunodeficiency and drug-resistant virus
Jan van Lunzen et al.
MOLECULAR THERAPY (2007)
Gene transfer in humans using a conditionally replicating lentiviral vector
Bruce L. Levine et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
T-cell protection and enrichment through lentiviral CCR5 intrabody gene delivery
C. H. Swan et al.
GENE THERAPY (2006)
Impact of gene-modified T cells on HIV infection dynamics
D von Laer et al.
JOURNAL OF THEORETICAL BIOLOGY (2006)
Gene-based immunotherapy for human immunodeficiency virus infection and acquired immunodeficiency syndrome
Boro Dropulic et al.
HUMAN GENE THERAPY (2006)
Setting the stage for bench-to-bedside movement of anti-HIV RNA inhibitors-gene therapy for AIDS in macaques
SE Braun et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2006)
Inhibition of simian/human immunodeficiency virus replication in CD4+ T cells derived from lentiviral-transduced CD34+ hematopoietic cells
SE Braun et al.
MOLECULAR THERAPY (2005)
Long-term inhibition of HIV-1 infection in primary hematopoietic cells by lentiviral vector delivery of a triple combination of anti-HIV shRNA, anti-CCR5 ribozyme, and a nucleolar-localizing TAR decoy
MJ Li et al.
MOLECULAR THERAPY (2005)
Preferential survival of CD4+ T lymphocytes engineered with anti-human immunodeficiency virus (HIV) genes in HIV-infected individuals
RA Morgan et al.
HUMAN GENE THERAPY (2005)
Determinants of human immunodeficiency virus type 1 resistance to membrane-anchored gp41-derived peptides
S Lohrengel et al.
JOURNAL OF VIROLOGY (2005)
Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death:: a prospective cohort study
JAC Sterne et al.
LANCET (2005)
Selective survival of peripheral blood lymphocytes in children with HIV-1 following delivery of an anti-HIV gene to bone marrow CD34+ cells
GM Podsakoff et al.
MOLECULAR THERAPY (2005)
Long-term survival and concomitant gene expression of ribozyme-transduced CD4+ T-lymphocytes in HIV-infected patients
JL Macpherson et al.
JOURNAL OF GENE MEDICINE (2005)
Anti-human immunodeficiency virus hematopoietic progenitor cell-delivered ribozyme in a phase I study: Myeloid and lymphoid reconstitution in human immunodeficiency virus type-1-infected patients
RG Amado et al.
HUMAN GENE THERAPY (2004)
Safe two-plasmid production for the first clinical lentivirus vector that achieves >99% transduction in primary cells using a one-step protocol
XB Lu et al.
JOURNAL OF GENE MEDICINE (2004)
Antisense-mediated inhibition of human immunodeficiency virus (HIV) replication by use of an HIV type 1-based vector results in severely attenuated mutants incapable of developing resistance
XB Lu et al.
JOURNAL OF VIROLOGY (2004)
Inhibition of human immunodeficiency virus type 1 entry in cells expressing gp41-derived peptides
M Egelhofer et al.
JOURNAL OF VIROLOGY (2004)
Efficient lentiviral vector-mediated control of HIV-1 replication in CD4 lymphocytes from diverse HIV+ infected patients grouped according to CD4 count and viral load
LM Humeau et al.
MOLECULAR THERAPY (2004)
High-level transduction and gene expression in hematopoietic repopulating cells using a human imunodeficiency virus type 1-based lentiviral vector containing an internal spleen focus forming virus promoter
C Demaison et al.
HUMAN GENE THERAPY (2002)
Oncoretrovirus and lentivirus vectors pseudotyped with lymphocytic choriomeningitis virus glycoprotein: Generation, concentration, and broad host range
WR Beyer et al.
JOURNAL OF VIROLOGY (2002)
Membrane-anchored peptide inhibits human immunodeficiency virus entry
M Hildinger et al.
JOURNAL OF VIROLOGY (2001)
Share Paper
